| Large-scale prediction of long non-coding RNA functions in a coding–non-coding gene co-expression network Q Liao, C Liu, X Yuan, S Kang, R Miao, H Xiao, G Zhao, H Luo, D Bu, ... Nucleic acids research 39 (9), 3864-3878, 2011 | 576 | 2011 |
| NONCODE v3. 0: integrative annotation of long noncoding RNAs D Bu, K Yu, S Sun, C Xie, G Skogerbø, R Miao, H Xiao, Q Liao, H Luo, ... Nucleic acids research 40 (D1), D210-D215, 2012 | 453 | 2012 |
| Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma Y Mao, H Yang, H Xu, X Lu, X Sang, S Du, H Zhao, W Chen, Y Xu, T Chi, ... Gut 59 (12), 1687-1693, 2010 | 436 | 2010 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 408 | 2023 |
| dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers Z Yang, L Wu, A Wang, W Tang, Y Zhao, H Zhao, AE Teschendorff Nucleic acids research 45 (D1), D812-D818, 2017 | 330 | 2017 |
| Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma J Long, A Wang, Y Bai, J Lin, X Yang, D Wang, X Yang, Y Jiang, H Zhao EBioMedicine 42, 363-374, 2019 | 288 | 2019 |
| Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies Y Wang, KJ Han, XW Pang, HA Vaughan, W Qu, XY Dong, JR Peng, ... The Journal of Immunology 169 (2), 1102-1109, 2002 | 283 | 2002 |
| dbDEMC: a database of differentially expressed miRNAs in human cancers Z Yang, F Ren, C Liu, S He, G Sun, Q Gao, L Yao, Y Zhang, R Miao, ... BMC genomics 11, 1-8, 2010 | 270 | 2010 |
| Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition CZJ Lim, Y Zhang, Y Chen, H Zhao, MC Stephenson, NRY Ho, Y Chen, ... Nature communications 10 (1), 1144, 2019 | 188 | 2019 |
| Randomized controlled trial for time-restricted eating in healthy volunteers without obesity Z Xie, Y Sun, Y Ye, D Hu, H Zhang, Z He, H Zhao, H Yang, Y Mao Nature communications 13 (1), 1003, 2022 | 185 | 2022 |
| Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label … S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee, AC Yopp, J Zhou, ... The Lancet 402 (10415), 1835-1847, 2023 | 169 | 2023 |
| Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers J Mao, D Wang, J Long, X Yang, J Lin, Y Song, F Xie, Z Xun, Y Wang, ... Journal for Immunotherapy of Cancer 9 (12), 2021 | 169 | 2021 |
| Intraductal papillary neoplasm of the bile duct XS Wan, YY Xu, JY Qian, XB Yang, AQ Wang, L He, HT Zhao, XT Sang World Journal of Gastroenterology: WJG 19 (46), 8595, 2013 | 166 | 2013 |
| Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis R Miao, H Luo, H Zhou, G Li, D Bu, X Yang, X Zhao, H Zhang, S Liu, ... Journal of hepatology 61 (4), 840-849, 2014 | 157 | 2014 |
| Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure H Yang, L Sun, Y Pang, D Hu, H Xu, S Mao, W Peng, Y Wang, Y Xu, ... Gut 70 (3), 567-574, 2021 | 153 | 2021 |
| NONCODE v2. 0: decoding the non-coding S He, C Liu, G Skogerbø, H Zhao, J Wang, T Liu, B Bai, Y Zhao, R Chen Nucleic acids research 36 (suppl_1), D170-D172, 2007 | 143 | 2007 |
| Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma G Li, H Zhang, X Wan, X Yang, C Zhu, A Wang, L He, R Miao, S Chen, ... BioMed research international 2014 (1), 780521, 2014 | 142 | 2014 |
| ncFANs: a web server for functional annotation of long non-coding RNAs Q Liao, H Xiao, D Bu, C Xie, R Miao, H Luo, G Zhao, K Yu, H Zhao, ... Nucleic acids research 39 (suppl_2), W118-W124, 2011 | 138 | 2011 |
| A four‐gene‐based prognostic model predicts overall survival in patients with hepatocellular carcinoma J Long, L Zhang, X Wan, J Lin, Y Bai, W Xu, J Xiong, H Zhao Journal of cellular and molecular medicine 22 (12), 5928-5938, 2018 | 130 | 2018 |
| Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma J Lin, XU Yang, J Long, S Zhao, J Mao, D Wang, Y Bai, J Bian, L Zhang, ... Hepatobiliary surgery and nutrition 9 (4), 414, 2020 | 129 | 2020 |
